Khaled Tolba
Hematology & Oncology · Seattle, WANPI 1093828311
Payments from drug & device makers
Across 88 payments — averaging $3433.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$104K
- E.r. Squibb & Sons, L.L.C.$70K
- Merck$54K
- Genentech, Inc.$41K
- Novartis$18K
- Foundation Medicine, Inc.$5K
- plus $11K from 3 others
Across 3 payments — averaging $1122.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$3K
What the payments were for
- Consulting fees$10,20720%
- Speaking & faculty fees$32,79466%
- Travel & lodging$6,30513%
- Food & beverage$6561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $103,737 |
| E.r. Squibb & Sons, L.L.C. | 12 | $69,570 |
| Merck | 24 | $53,855 |
| Genentech, Inc. | 11 | $41,498 |
| Novartis | 6 | $17,669 |
| Foundation Medicine, Inc. | 6 | $5,277 |
| Astrazeneca UK Limited | 2 | $4,892 |
| Boehringer Ingelheim International GmbH | 11 | $4,000 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $1,654 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$20,045
- FOUNDATIONONE LIQUID$5,187
- FOUNDATIONFOCUS$5,187
- FOUNDATIONONE CDX$5,187
- FOUNDATIONONE HEME$5,187
- FOUNDATIONONE$5,187
- IMFINZI$4,101
- GILOTRIF$3,908
- TAGRISSO$2,220
How this compares
$302,152 in reported general payments places this provider in the 70th percentile of 349 hematology & oncology providers in Washington.
Other hematology & oncology in Seattle
- Mazyar ShadmanSeattle$36.8M
- Ryan CassadaySeattle$22.7M
- John PesandoSeattle$15.7M
- Andrew CowanSeattle$15M
- Stephen SmithSeattle$12.6M
- Stephanie LeeSeattle$11.2M
- Sara HurvitzSeattle$10.9M
- Chaitra UjjaniSeattle$10.6M
- Lawrence FongSeattle$9.7M
- Cameron TurtleSeattle$8.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.